| Start Date: | 1/18/2013 | Start Time: | 4:00 PM |
| End Date: | 1/18/2013 | End Time: | 5:30 PM |
|
Event Description
Dr. Nina Tandon, postdoctoral researcher in the department of pharmacology at Columbia University, and associate adjunct professor of electrical engineering at The Cooper Union, will discuss how tissue engineering has resulted in some remarkable feats to date: it's been two years since the first tissue-engineered tracheal transplantation, and in the two years since, a three-year old girl was implanted with a tissue engineered blood vessel, where the scaffold has been resorbed, thereby leaving in place a functioning vessel. The field's paradigm of using scaffolds, growth factors, and bioreactors produces tissues that indeed may serve as replacement parts for the human body; however; they can also serve as high-fidelity platforms for studying human disease progression, and for discovering disease cures. In this talk, Dr. Tandon will introduce her research in bio-roeactor design, and in particular, her use of electrical signaling for cardiac, skin, and neural tissue engineering. She will also introduce some of her work in implementing scalable advanced bioreactor systems for the generation of predictable density and behavior. Finally, she will share her thoughts about the context of tissue engineering as it relates to other trends in manufacturing, information and biotechnology (e.g., open source hardware and software, 3-D bio-printing, new collaborative tools, etc.), and will introduce several possible research directions for the future of the field, including scalable, high-throughput tissue engineering bioreactor platforms for drug discovery, tissue engineering a model of stress-induced cardiovascular disease, and studying viral migration from non-human into human tissues. |
|
Location:
The Papadakis Integrated Sciences Building, located on the northeast corner of 33rd and Chestnut Streets. |
Audience:
AlumniCurrent StudentsFacultyProspective StudentsPublicStaff |
|
